This is an emerging and important area of aesthetic medicine, and it is one that Dr Dorota, our award-winning founder, NHS ENT surgical registrar, and Key Opinion Leader for leading aesthetic brands, is expertly equipped to address
Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as key therapies for the treatment of obesity and type 2 diabetes, with several agents demonstrating cardiovascular benefits 7,8,9,10,11,12
Patients should maintain regular communication with their healthcare providers about any cognitive or emotional changes they experience while taking the medication
Many researchers use both together for comprehensive repair protocols
Vitamin shots From $50 + HST Single-dose boosts